The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

In a recent study posted to the medRxiv* preprint server, researchers developed a personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes, i.e., sodium-glucose ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

Preoperative patient evaluation should include an assessment of endocrine, metabolic, physical, nutritional, and psychologic health. Preoperative patient evaluation should include routine clinical ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

The US Food and Drug Administration (FDA) has expanded the indication for Tandem Diabetes Care’s Control-IQ+ Technology to include people with type 2 diabetes (T2D). The next-generation Control-IQ+ ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), insulin resistance, and a decrease in insulin production. For some people, type 2 diabetes can be managed with ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...